Source: ForImmediateRelease

Press Release: Accelovance : Accelovance & Linical Merge Organizations to Form a Best-in-Class CRO with Increased Global Reach

Travel & Tourism Industry release: ROCKVILLE, Md., March 27, 2018 /PRNewswire/ - Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in oncology, vaccines, and general medicine announced today that it has signed a merger agreement with Linical, a leading CRO based in Asia in the fields of oncology, immunology, and neurology. The transaction is • Read More »The post Accelovance & Linical Merge Organizations to Form a Best-in-Class CRO with Increased Global Reach appeared first on forimmediaterelease.net.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Vita Lanoce's photo - CEO of Linical Accelovance

CEO

Vita Lanoce

CEO Approval Rating

82/100

Read more